Effect of strontium ranelate on pain behavior in an experimental model of osteoarthritis

Effect of strontium ranelate on pain behavior in an experimental model of osteoarthritis

Strontium ranelate (SrRan) is a drug usually prescribed to treat osteoporosis, with proven effects of decreasing the risk of fractures and an indication of reducing the progression of osteoarthritis (OA). This study aimed to investigate the effects of SrRan as either a prophylactic or a treatment dr...

Full description

Bibliographic Details
Main Authors:	T.A. Rodrigues, A.J.B. Sampaio Junior, I.D.P. Nunes, M.S.S. Cartágenes, J.B.S. Garcia
Format:	Article
Language:	English
Published:	Associação Brasileira de Divulgação Científica
Series:	Brazilian Journal of Medical and Biological Research
Subjects:	Osteoarthritis Strontium ranelate Pain Treatment Prophylaxis
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2017000900602&lng=en&tlng=en

Similar Items

Strontium ranelate as a possible disease-modifying osteoarthritis drug: a systematic review
by: T.A. Rodrigues, et al.
Published: (2018-06-01)

Prophylactic and Therapeutic Use of Strontium Ranelate Reduces the Progression of Experimental Osteoarthritis
by: Thiago A. Rodrigues, et al.
Published: (2018-09-01)

Chondroprotective effect of melatonin and strontium ranelate in animal model of osteoarthritis
by: Kássya Mycaela Paulino Silva, et al.
Published: (2021-04-01)

PATHOGENESIS OF OSTEOARTHRITIS AND SUBSTANTIATION OF THE USE OF STRONTIUM RANELATE
by: Elena Mikhailovna Zaitseva, et al.
Published: (2014-02-01)

The Short-Term Effects of Strontium Ranelate on Pain and Bone Mineral Density in Postmenopausal Women with Osteoporosis
by: Halil Koyuncu, et al.
Published: (2012-08-01)

Strontium ranelate in the treatment of postmenopausal osteoporosis: results of administration in clinical practice
by: N V Toroptsova, et al.
Published: (2008-06-01)

Pathogenetic treatment with strontium ranelate in women with postmenopausal osteoporosis
by: Olga Borisovna Yershova
Published: (2010-12-01)

THE PLACE OF STRONTIUM RANELATE IN THE TREATMENT OF PATIENTS WITH OSTEOPOROSIS (RESULTS OF THE MARC PROGRAM)
by: O. A. Nikitinskaya, et al.
Published: (2018-09-01)

STRONTIUM RANELATE IS THE DRUG OF CHOICE IN THE TREATMENT OF OSTEOPOROSIS
by: Nataliya Vladimirovna Toroptsova
Published: (2010-09-01)

STRONTIUM RANELATE IS THE DRUG OF CHOICE IN THE TREATMENT OF OSTEOPOROSIS
by: Nataliya Vladimirovna Toroptsova
Published: (2010-09-01)

Comparison of the Effects of Strontium Ranelate and Raloxiphene on Bone Mineral Density in Postmenopausal Osteoporosis - Original Investigation
by: Figen Yılmaz, et al.
Published: (2009-04-01)

Strontium ranelate is a drug to treat osteoarthrosis
by: Oksana Anatolyevna Nikitinskaya
Published: (2013-03-01)

Comparison of Effectiveness of Strontium Ranelate and Alendronate Sodium in Postmenopausal Osteoporosis - Original Investigation
by: Kurtuluş Kaya, et al.
Published: (2009-12-01)

Effets du ranélate de strontium, un traitement anti-ostéoporotique, sur le minéral osseux
by: Doublier, Audrey
Published: (2011)

Cytotoxicity Analysis of Strontium Ranelate on Cultured Human Periodontal Ligament Fibroblasts: A Preliminary Report
by: Kürşat Er, et al.
Published: (2008-08-01)

Cumulative Effects Of Strontium Ranelate and Impact Exercise On Bone Mass In Ovariectomized Rats
by: Priscilla Aveline, et al.
Published: (2021-03-01)

Reversed phase HPLC for strontium ranelate: Method development and validation applying experimental design
by: Kovács Béla, et al.
Published: (2018-06-01)

POSSIBILITY OF BONE METABOLISM MODULATOR (STRONTIUM RANELATE) USAGE FOR THE TREATMENT OF WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS AND ARTERIAL HYPERTENSION
by: N. J. Hozjainova, et al.
Published: (2016-01-01)

The Comparison of the Effect of Risedronate and Strontium Ranelate on Bone Mineral Density in Postmenopausal Women
by: Figen Yılmaz, et al.
Published: (2012-08-01)

Strontium ranelate inhibits wear particle-induced aseptic loosening in mice
by: Tianxiang Geng, et al.
Published: (2018-07-01)

Strontium ranelate promotes chondrogenesis through inhibition of the Wnt/β-catenin pathway
by: Hao Yu, et al.
Published: (2021-05-01)

A new contralateral atypical femoral fracture despite sequential therapy with teriparatide and strontium ranelate
by: Hanh H Nguyen, et al.
Published: (2017-06-01)

Development and Validation of an UV-Spectrophotometric Method for the Assay of Strontium Ranelate and HPLC Stability Testing from Bulk and Pharmaceutical Dosage Form
by: Kovács Béla, et al.
Published: (2019-06-01)

Strontium ranelate treatment in a postmenopausal woman with osteonecrosis of the jaw after long-term oral bisphosphonate administration: a case report
by: Pan WL, et al.
Published: (2017-07-01)

Facilitated and Controlled Strontium Ranelate Delivery Using GCS-HA Nanocarriers Embedded into PEGDA Coupled with Decortication Driven Spinal Regeneration
by: Chiang CW, et al.
Published: (2021-06-01)

Osteoporosis: from cost-effect characteristics to clinical efficacy and safety of strontium ranelate (bivaios)
by: Ia S Dydykina, et al.
Published: (2008-05-01)

Osteoinductivity and Antibacterial Properties of Strontium Ranelate-Loaded Poly(Lactic-co-Glycolic Acid) Microspheres With Assembled Silver and Hydroxyapatite Nanoparticles
by: Zhenyang Mao, et al.
Published: (2018-04-01)

STRONTIUM RANELATE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS: IMPACT OF VITAMIN D RECEPTOR AND MONOCYTE CHEMOATTRACTANT PROTEIN-1 GENE POLYMORPHISMS ON BONE MINERAL DENSITY: A PILOT STUDY
by: M. Yu. Krylov, et al.
Published: (2017-07-01)

Impacto de una alerta sanitaria sobre la utilización de ranelato de estroncio Impact of a health safety warning on strontium ranelate utilization
by: Eduardo Carracedo-Martínez, et al.
Published: (2010-04-01)

Effets du ranélate de strontium et de l’exercice physique sur le tissu osseux de rates ovariectomisées : rôle de l’ostéocyte
by: Aveline, Priscilla
Published: (2015)

Clinical and radiographic diagnostic study of strontium ranelate andmetal-substituted hydroxyapatite bone graft materials in diabetesmellitus with chronic periodontitis
by: Omar Khashaba, et al.
Published: (2020-12-01)

Current approaches to the diagnosis and treatment of postmenopausal osteoporosis
by: Irina Aleksandrovna Baranova, et al.
Published: (2009-10-01)

Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss
by: Anne-Priscille Trouvin, et al.
Published: (2010-11-01)

Treatment of primary osteoporosis in men
by: Giusti A, et al.
Published: (2014-12-01)

STUDY OF ENDOTHELIAL PROTECTIVE AND OSTEOPROTECTIVE PROPERTIES OF ROSUVASTATIN, L-NORVALINE AND THEIR COMBINATIONS IN EXPERIMENTAL OSTEOPOROSIS
by: M. S. SOBOLEV, et al.
Published: (2017-12-01)

Advances in Osteoporotic Bone Tissue Engineering
by: Cosmin Iulian Codrea, et al.
Published: (2021-01-01)

Controlled SrR Delivery by the Incorporation of Mg Particles on Biodegradable PLA-Based Composites
by: Ana Ferrández-Montero, et al.
Published: (2021-03-01)

Systemic administration of strontium ranelate to enhance the osseointegration of implants: systematic review of animal studies
by: Cassio Rocha Scardueli, et al.
Published: (2018-07-01)

POSSIBILITIES AND PROSPECTS OF DOUBLE EFFECT DRUGS APPLICATION FOR SYSTEMIC OSTEOPOROSIS PHARMACOTHERAPY OF PATIENTS WITH BONE FRACTURES
by: A. Y. Kochish, et al.
Published: (2012-06-01)

Comparative pharmacoeconomic analysis of the use of Bonviva® (ibandronat) to prevent fractures in postmenopausal osteoporosis
by: E A Pyadushkina, et al.
Published: (2012-12-01)

Cannot write session to /tmp/vufind_sessions/sess_e9hsnugs4fbhkbaqgr3fqu7ea6